BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12436294)

  • 1. [Incidence and differential diagnosis of chronic eosinophilic leukemia].
    Büsche G; Nolte M; Schlue J; Kreft A; Kreipe HH
    Pathologe; 2002 Nov; 23(6):419-25. PubMed ID: 12436294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome.
    Bain BJ
    Br J Haematol; 1996 Oct; 95(1):2-9. PubMed ID: 8857931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic eosinophilic leukemia with symptoms resembling Budd-Chiari syndrome due to liver infiltration].
    Iriuchishima H; Ogawa Y; Hoshino T; Yoshida T; Sato K; Takagi H; Toyama K; Tsukamoto N; Jinbo T
    Rinsho Ketsueki; 2007 Jun; 48(6):505-9. PubMed ID: 17633100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia].
    Chrobák L; Voglová J
    Vnitr Lek; 2005 Dec; 51(12):1385-93. PubMed ID: 16430106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic leukemia: a myeloproliferative disorder distinct from the hypereosinophilic syndrome.
    Kueck BD; Smith RE; Parkin J; Peterson LC; Hanson CA
    Hematol Pathol; 1991; 5(4):195-205. PubMed ID: 1794968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders.
    Kelemen K; Saft L; Craig FE; Orazi A; Nakashima M; Wertheim GB; George TI; Horny HP; King RL; Quintanilla-Martinez L; Wang SA; Rimsza LM; Reichard KK
    Am J Clin Pathol; 2021 Feb; 155(2):179-210. PubMed ID: 33367563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic eosinophilic leukemia with complex karyotypic abnormalities including trisomy 8].
    Wakabayashi S; Yamamoto K; Arai A; Miura O
    Rinsho Ketsueki; 2008 Jul; 49(7):510-5. PubMed ID: 18709984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia.
    Cilloni D; Messa F; Martinelli G; Gottardi E; Arruga F; Defilippi I; Carturan S; Messa E; Fava M; Giugliano E; Rosso V; Catalano R; Merante S; Nicoli P; Rondoni M; Ottaviani E; Soverini S; Tiribelli M; Pane F; Baccarani M; Saglio G
    Leukemia; 2007 Jul; 21(7):1442-50. PubMed ID: 17508006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome.
    Wang SA; Hasserjian RP; Tam W; Tsai AG; Geyer JT; George TI; Foucar K; Rogers HJ; Hsi ED; Rea BA; Bagg A; Bueso-Ramos CE; Arber DA; Verstovsek S; Orazi A
    Haematologica; 2017 Aug; 102(8):1352-1360. PubMed ID: 28495918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Eosinophilia--a challenging differential diagnosis].
    Seifert M; Gerth J; Gajda M; Pester F; Pfeifer R; Wolf G
    Med Klin (Munich); 2008 Aug; 103(8):591-7. PubMed ID: 18807233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic eosinophilic leukemia/hypereosinophilic syndrome.
    Gotlib J
    Cancer Treat Res; 2008; 142():69-106. PubMed ID: 18283783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Eosinophilic leukemia].
    Voglová J; Chrobák L; Kerekes Z; Radochová D; Spacek J; Balícek P
    Vnitr Lek; 1989 Apr; 35(4):389-94. PubMed ID: 2741358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexplained hypereosinophilia and the need for cytogenetic and molecular genetic analyses.
    Smith KJ; Jacobson E; Hamza S; Skelton H
    Arch Dermatol; 2004 May; 140(5):584-8. PubMed ID: 15148104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypereosinophilic syndrome, chronic eosinophilic leukemia, and mast cell disease.
    Pardanani A; Verstovsek S
    Cancer J; 2007; 13(6):384-91. PubMed ID: 18032976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytogenetic study on eosinophilia].
    Zhang Y; He Q; Huang XJ; Jiang H; Yang SM; Lu J; Qing YZ; Shi Y; Dang H; Qiu JY; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):454-7. PubMed ID: 17605843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapy.
    Gotlib J; Cross NC; Gilliland DG
    Best Pract Res Clin Haematol; 2006; 19(3):535-69. PubMed ID: 16781488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is hypereosinophilic syndrome a potentially malignant condition?].
    Bellusci M; Nalli G; Mengoni A; Carnevale-Maffè G; Sessa F; Ascari E
    Recenti Prog Med; 1991 Jan; 82(1):19-23. PubMed ID: 2028071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis, classification, and therapy of eosinophilia and eosinophil disorders.
    Valent P
    Blood Rev; 2009 Jul; 23(4):157-65. PubMed ID: 19246139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tissue hypereosinophilia].
    Desreumaux P; Wallaert B; Janin A
    Rev Prat; 2000 Mar; 50(6):630-5. PubMed ID: 10808320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case of chronic eosinophilic leukemia with deletion of chromosome 16 and hepatitis C.
    Kamineni P; Baptiste A; Hassan M; Dawkins FW; Zaidi S; Tefferi A; Lindsey M; Taddesse-Heath L
    J Natl Med Assoc; 2006 Aug; 98(8):1356-60. PubMed ID: 16916138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.